Dutta told CNBC-TV18, "I am bearish on Ranbaxy Laboratories at the moment, I would expect the price post open offer, even if there isn't as an immediate steep fall to the Rs 430 levels. I would expect the price post open offer to settle around Rs 464-470, so if you can tender for the open offer at Rs 737, then that obviously makes sense and also because of the time factor there is no chance of buying the share today and going for an open offer. So if you are holding the stock, go with an open offer, if you are not holding the stock probably I would be bearish on it. I would be looking at Rs 475-470 by tomorrow."